Distributing Publicly-Funded Influenza Vaccine—Community Pharmacies’ Perspectives on Acquiring Vaccines from Public Health and from Private Distributors in Ontario, Canada

Fonseca, Joseph, Violette, Richard, Houle, Sherilyn K.D., and Waite, Nancy M. (2021) Distributing Publicly-Funded Influenza Vaccine—Community Pharmacies’ Perspectives on Acquiring Vaccines from Public Health and from Private Distributors in Ontario, Canada. Pharmacy, 9 (2). 94.

[img]
Preview
PDF (Published Version) - Published Version
Available under License Creative Commons Attribution.

Download (228kB) | Preview
View at Publisher Website: https://doi.org/10.3390/pharmacy9020094
 
2


Abstract

Objectives: To explore community pharmacies’ experience with two models of distribution for publicly-funded influenza vaccines in Ontario, Canada—one being publicly-managed (2015–2016 influenza season) and one involving private pharmaceutical distributors (2016–2017 season).

Methods: Online surveys were distributed to community pharmacies across Ontario during the 2015–2016 and 2016–2017 influenza seasons with sampling proportional to Ontario Public Health Unit catchment populations. Quantitative data were analyzed descriptively and inferentially and qualitative data were summarized for additional context.

Results: Order fulfillment appeared more responsive with the addition of private distributors in 2016–2017, as more pharmacies reported shorter order fulfillment times (p < 0.01); however, pharmacies reported significantly more days with zero on-hand inventory in 2016–2017 (p < 0.01), as well as more instances of patients being turned away due to vaccine unavailability (p < 0.05). In both seasons, a similar proportion of pharmacies reported slower order fulfillment and limited order quantities early in the season. Improved availability early in the season when patient demand is highest, more vaccines in a pre-filled syringe format, and better communication from distributors on product availability dates were recommended in qualitative responses.

Conclusions: Introducing private distributors for the management and fulfillment of pharmacies’ orders for the publicly funded influenza vaccine appeared to have mixed results. While key concerns surrounding the frequency, responsiveness, and method of delivery were addressed by this change, challenges remain—in particular, acquiring sufficient vaccine early in the season to meet patient demand. As pharmacies become more prominent as vaccination sites, there are several opportunities to ensure that patient demand is met in this setting.

Item ID: 84174
Item Type: Article (Research - C1)
ISSN: 2226-4787
Copyright Information: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)
Date Deposited: 26 Nov 2024 01:19
Downloads: Total: 2
Last 12 Months: 2
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page